InvestSMART

Aroa Biosurgery Limited (ASX: ARX) - Announcements

Current share price for ARX : $0.490 0.005 (1.03%)+

ASX company news and announcements for Aroa Biosurgery Limited (ARX) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All Aroa Biosurgery Limited (ARX) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than Aroa Biosurgery Limited (ARX), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for Aroa Biosurgery Limited (ARX)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$169 Aroa Biosurgery H1 FY27 Results & Investor Event 4 Nov 2026 8:49AM $0.490 $0.490 fallen by 0%
$169 AROA Appoints Mark Dunwoodie as CFO 3 Nov 2026 8:51AM $0.485 $0.490 risen by 1.03%
$169 Change in substantial shareholding from AEF 19 Oct 2026 9:18AM $0.510 $0.490 fallen by 3.92%
$169 Molnlycke to Co-promote Endoform In the US 16 Oct 2026 8:58AM $0.540 $0.490 fallen by 9.26%
$169 Notification of cessation of securities - ARX 12 Oct 2026 4:27PM $0.505 $0.490 fallen by 2.97%
$169 Investor Presentation - Symphony RCT 12 Oct 2026 8:46AM $0.520 $0.490 fallen by 5.77%
$169 Invite to Investor Webinar on Symphony RCT 7 Oct 2026 10:01AM $0.530 $0.490 fallen by 7.55%
$169 Investor Presentation - MASTRR Interim Analysis 7 Oct 2026 8:39AM $0.500 $0.490 fallen by 2%
$169 Change in substantial holding 6 Oct 2026 3:33PM $0.505 $0.490 fallen by 2.97%
$169 Symphony Significantly Improves DFU Healing 5 Oct 2026 9:36AM $0.490 $0.490 fallen by 0%
$169 Invite to Investor Webinar on MASTRR Interim Analysis 29 Sep 2026 9:29AM $0.500 $0.490 fallen by 2%
$169 Myriad MASTRR Study Reports Low Infection Rates 4 Sep 2026 9:01AM $0.540 $0.490 fallen by 9.26%
$169 Change of Director's Interest Notice - BW 28 Aug 2026 12:57PM $0.570 $0.490 fallen by 14.04%
$169 Notification regarding unquoted securities - ARX 28 Aug 2026 12:54PM $0.570 $0.490 fallen by 14.04%
$169 Final Director's Interest Notice - JD 21 Aug 2026 10:45AM $0.575 $0.490 fallen by 14.78%
$169 Results of Annual General Meeting 19 Aug 2026 2:33PM $0.575 $0.490 fallen by 14.78%
$169 CEO Presentation - AGM 19 Aug 2026 8:51AM $0.580 $0.490 fallen by 15.52%
$169 Chairman's Address - AGM 19 Aug 2026 8:44AM $0.580 $0.490 fallen by 15.52%
$169 Notification of cessation of securities - ARX 12 Aug 2026 9:50AM $0.605 $0.490 fallen by 19.01%
$169 Notification regarding unquoted securities - ARX 12 Aug 2026 9:50AM $0.605 $0.490 fallen by 19.01%
$169 Change in substantial shareholding from AEF 7 Aug 2026 9:33AM $0.565 $0.490 fallen by 13.27%
$169 Notification regarding unquoted securities - ARX 28 Jul 2026 10:53AM $0.570 $0.490 fallen by 14.04%
$169 Commercial Leadership Appointments 28 Jul 2026 9:30AM $0.580 $0.490 fallen by 15.52%
$169 Notice of Annual General Meeting/Proxy Form 24 Jul 2026 3:49PM $0.560 $0.490 fallen by 12.50%
$169 Notification of cessation of securities - ARX 14 Jul 2026 10:15AM $0.575 $0.490 fallen by 14.78%

1 - 25 of 776 results

Page 1 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.